Hemodynamic properties of a new derivative of theophylline: bamifylline
Moret, P.R.; Fournet, P.C.; Boufas, D.
Schweizerische Medizinische Wochenschrift 100(10): 462-467
1970
ISSN/ISBN: 0036-7672 PMID: 5423732 Document Number: 19014
Document emailed within 1 workday
Related Documents
Alciato, P.; Cantone, P.A.; Fico, D.; Gagliardini, R.; Petrella, V. 1990: Bamifylline in the therapy of asthmatic syndromes. Efficacy and side effects vs delayed-action theophylline anhydride Minerva Medica 81(1-2): 93-97Serajuddin, A.T. 1986: Comparative thermal properties of the monohydrates of sodium theophylline and theophylline Journal of Pharmacy and Pharmacology 38(2): 93-96
Goñalons, E.; Grau, T.; Vericat, F.; Tintoré, I.; Colomé, J. 1971: Diuretic activity of a new theophylline derivative Bollettino Chimico Farmaceutico 110(11): 653-657
Kovalev, G.V.; Gurbanov, K.G.; Luk'ianenko, N.G.; Basok, S.S. 1988: Cardio- and hemodynamic effects of a crown ether derivative and an analysis of its cardiotropic action in an experiment Farmakologiia i Toksikologiia 51(3): 36-38
Batrak, G.E.; Zlenko, E.T.; Khrustalev, S.I.; Khmel', M.P.; Malinovskiĭ, M.S. 1979: Pharmacological properties of a new benzimidazole derivative Farmakologiia i Toksikologiia 42(5): 511-515
Kitamura, M.; Nimura, A.; Kunimoto, K.; Segawa, H.; Shimidzu, T. 1991: Synthesis and properties of oligonucleotide derivative with P(V) porphyrin Nucleic Acids Symposium Series 25: 13-14
Thiele, K.; Jahn, U.; Geissmann, F.; Zirngibl, L. 1984: New biologically active theophylline derivatives. Synthesis and pharmacologic properties of flufylline and fluprofylline Arzneimittel-Forschung 34(1): 1-4
Shapovalova, V.O.; Shapovalov, V.V. 1998: Spasmophilia in children and the anticonvulsant properties of a new Ukrainian preparation containing a pyrimidine derivative Fiziolohichnyi Zhurnal 44(5-6): 102-105
Berti, F.; Magni, F.; Rossoni, G.; Schiantarelli, P.; Bongrani, S.; Pasargiklian, R. 1988: New pharmacological data on the bronchospasmolytic activity of bamifylline Arzneimittel-Forschung 38(1): 40-44
Shibasaki, K.; Uchida, W.; Shirai, Y.; Inagaki, O.; Asano, M.; Takenaka, T. 1994: Pharmacological properties of YM-15430-1, a 1,4-dihydropyridine derivative with beta 1-adrenoceptor-blocking activity Archives Internationales de Pharmacodynamie et de Therapie 328(2): 213-224
Kozlovskaia, M.M.; Inozemtsev, A.N.; Nikitin, S.V.; Gochmuradov, A.G.; Iakushev, R.A.; Chabak-Gorbach, R. 1995: Comparison of neurotropic and stress-protective properties of piracetam and the derivative pyrido]1,2-a]pyrimidine Biulleten' Eksperimental'noi Biologii i Meditsiny 119(3): 299-301
Mihaljevic, T.; Leskosek, B.; von Segesser, L.K.; Tönz, M.; Turina, M. 1994: Hemodynamic properties of the hemopump Helvetica Chirurgica Acta 60(6): 1159-1162
Hnatowich, D.J.; Mardirossian, G.; Fogarasi, M.; Sano, T.; Smith, C.L.; Cantor, C.R.; Rusckowski, M.; Winnard, P. 1996: Comparative properties of a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in mice Journal of Pharmacology and Experimental Therapeutics 276(1): 326-334
Takeyama, H.; Kawashima, K.; Yamada, K.; Ito, Y. 1979: Properties of interferon induced by purified protein derivative of tuberculin in mice sensitized with BCG or cell-wall skeleton of BCG Gan 70(4): 421-428
Nakayama, K.; Kurihara, J.; Miyajima, Y.; Ishii, K.; Kato, H. 1985: Calcium antagonistic properties of nicardipine, a dihydropyridine derivative assessed in isolated cerebral arteries and cardiac muscle Arzneimittel-Forschung 35(4): 687-693
Laaban, J.P.; Dupeyron, J.P.; Guyon, F.; Drieu, L.; Rochemaure, J.; Fabiani, P. 1986: Intravenous theophylline: adaptation of dosage to blood theophylline levels at admission and to clearance Annales de Medecine Interne 137(5): 415-419
Zimmermann, I.; Schulz, H.U.; Ulmer, W.T. 1978: Blood level courses after i.v., i.m. and p.o. administration of theophylline ethylendiamine and pH-neutral solution of theophylline Arzneimittel-Forschung 28(9): 1652-1654
Wemhöner, S.; Oellerich, M.; Sybrecht, G. 1981: Theophylline therapy in obstructive respiratory diseases. 1. Bioavailability and pharmacokinetics of various theophylline preparations Praxis und Klinik der Pneumologie 35(1): 36-41
Mano, K. 1996: The development of slow-release theophylline products and revaluation of theophylline's role as a bronchodilator Nihon Rinsho. Japanese Journal of Clinical Medicine 54(11): 3093-3101
Moore, L.D.; Taylor, A.T. 1988: Theophylline dosing and theophylline level testing in a family practice population Journal of Family Practice 27(1): 57-61